Xeris Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 11.93 M | $97.09 M | 3.39% | 7.65% |
| VANGUARD GROUP INC | 11/07/2025 | 9.83 M | $80.00 M | 0.11% | 6.30% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 5.84 M | $47.54 M | 52.26% | 3.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 4.14 M | $33.71 M | 13.41% | 2.65% |
| STATE STREET CORP | 11/14/2025 | 3.74 M | $30.43 M | -1.19% | 2.40% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 3.27 M | $26.66 M | 5.99% | 2.10% |
| MORGAN STANLEY | 11/14/2025 | 3.22 M | $26.21 M | -11.61% | 2.06% |
| NUVEEN, LLC | 11/12/2025 | 2.83 M | $23.02 M | 8.75% | 1.81% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.62 M | $21.32 M | 26.46% | 1.68% |
| ROSALIND ADVISORS, INC. | 11/13/2025 | 1.80 M | $14.62 M | -16.69% | 1.15% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.80 M | $14.62 M | -20.96% | 1.15% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 1.79 M | $14.58 M | -14.99% | 1.15% |
| UBS GROUP AG | 11/13/2025 | 1.78 M | $14.51 M | 682.36% | 1.14% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 1.70 M | $13.83 M | 38.34% | 1.09% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.62 M | $13.21 M | -21.04% | 1.04% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.61 M | $13.14 M | 32.92% | 1.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.59 M | $12.98 M | -4.13% | 1.02% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.57 M | $12.76 M | 112.73% | 1.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.45 M | $11.78 M | 154.89% | 0.93% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 1.43 M | $11.67 M | -7.86% | 0.92% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.36 M | $11.10 M | 5.38% | 0.87% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 1.36 M | $11.05 M | -24.76% | 0.87% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 1.21 M | $9.86 M | 48.45% | 0.78% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 1.03 M | $8.42 M | 4.04% | 0.66% |
| KNOTT DAVID M JR | 11/12/2025 | 1.02 M | $8.26 M | -4.25% | 0.65% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 983.60 K | $8.01 M | -6.23% | 0.63% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 921.10 K | $7.50 M | 140.35% | 0.59% |
| JANE STREET GROUP, LLC | 11/14/2025 | 913.76 K | $7.44 M | 2,832.00% | 0.59% |
| JPMORGAN CHASE & CO | 11/26/2025 | 905.08 K | $7.37 M | -12.32% | 0.58% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 893.24 K | $7.27 M | -15.48% | 0.57% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 11/06/2025 | 750.03 K | $6.11 M | 3.34% | 0.48% |
| FEDERATED HERMES, INC. | 11/03/2025 | 704.38 K | $5.73 M | 1.88% | 0.45% |
| CENTERBOOK PARTNERS LP | 11/07/2025 | 698.20 K | $5.68 M | -56.20% | 0.45% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 679.08 K | $5.53 M | 138.64% | 0.44% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 623.96 K | $5.08 M | 156.48% | 0.40% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 603.24 K | $4.91 M | -20.25% | 0.39% |
| EAM INVESTORS, LLC | 11/14/2025 | 603.10 K | $4.85 M | 2.77% | 0.39% |
| INVESCO LTD. | 11/13/2025 | 583.11 K | $4.75 M | 576.51% | 0.37% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 581.72 K | $4.74 M | 3,466.64% | 0.37% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 580.96 K | $4.73 M | 45.50% | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 524.75 K | $4.27 M | -82.11% | 0.34% |
| REDMILE GROUP, LLC | 11/14/2025 | 451.10 K | $3.67 M | 0.00% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 439.84 K | $3.58 M | 16.63% | 0.28% |
| CITADEL ADVISORS LLC | 11/14/2025 | 437.61 K | $3.56 M | 100.00% | 0.28% |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | 11/14/2025 | 406.33 K | $3.31 M | 100.00% | 0.26% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 400.08 K | $3.26 M | 866.61% | 0.26% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/13/2025 | 375.70 K | $3.06 M | 100.00% | 0.24% |
| FMR LLC | 11/13/2025 | 360.18 K | $2.93 M | 10.34% | 0.23% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2025 | 350.53 K | $2.85 M | 26.08% | 0.22% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 350.17 K | $2.85 M | 100.00% | 0.22% |
Xeris Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 274 institutional investors and hedge funds held shares of Xeris Biopharma Holdings, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 11.93 M
VANGUARD GROUP INC: 9.83 M
D. E. Shaw & Co., Inc.: 5.84 M
GEODE CAPITAL MANAGEMENT, LLC: 4.14 M
STATE STREET CORP: 3.74 M
Qube Research & Technologies Ltd: 3.27 M
62.34% of Xeris Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 111.28 M shares in the last 24 months. This purchase volume represents approximately $912.53 M in transactions.